Targeted therapies for certain of these subtypes exist: luminal A breast cancers are oestrogen receptor alpha (ER) positive and are treated with ER pathway inhibitors, such as tamoxifen or aromatase inhibitors. The gene discussed is ESR1; the disease is breast cancer.